Evidence map›Paper›PMID 42194464›Full record

ArticleHealthcare (Basel, Switzerland)2026

The Structural Imbalance and Trajectory of Chinese National Policies on Medical-Preventive Integration: A Three-Dimensional Analysis of Policy Instruments (2015-2025).

Wenjie Xu, Chi Zhang, Yuqi Yang, Xinyi Du, Yongze Zhang, Fang Wu

Abstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wenjie XuSchool of International Pharmaceutical Business, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, China.ORCID 0009-0007-2122-4950
Chi ZhangSchool of International Pharmaceutical Business, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, China.
Yuqi YangSchool of International Pharmaceutical Business, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, China.
Xinyi DuSchool of International Pharmaceutical Business, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, China.
Yongze ZhangAdmission and Employment Office, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, China.
Fang WuSchool of International Pharmaceutical Business, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, China.

Funding

The General Project of the National Social Science Fund of China 22BGL252
6 · The paper itself

Abstract

BACKGROUND/

objectivesThe global health landscape is currently confronted with dual challenges from both infectious diseases and chronic conditions. Medical-preventive integration has emerged as a pivotal strategy to address these issues, aiming to create a comprehensive, closed-loop framework that spans disease prevention, treatment, rehabilitation, and healthcare, ultimately improving population health outcomes. In the Chinese context, existing policies remain fragmented, scattered across various healthcare-related regulations, and lack systematic and comprehensive analysis. This policy fragmentation may impede the creation of synergistic effects essential for the effective implementation of integrated healthcare strategies.

methodsThis study adopted a mixed-methods approach to analyze 85 national policies: a three-stage coding process identified 1088 policy nodes, and a three-dimensional framework (policy instruments (X) × full-cycle health service (Y) × integration stages (Z)) was applied to uncover systemic imbalances. Social network analysis and Latent Dirichlet Allocation (LDA) topic modeling were utilized to map interagency collaboration patterns and thematic shifts, which were visualized using Gephi and Sankey.

resultsThe analysis revealed that policy instruments are predominantly supply-side (45.04%) and environmental-side (40.35%), with demand-side instruments (14.61%) being notably underutilized, particularly in health financing. Rehabilitation services, representing just 8.27% of the policy focus, were identified as a significant gap in the comprehensive health service cycle. While 44.58% of the instruments facilitated collaboration of medical and preventive services, integration of medical-preventive management stagnated at 25.28%, reflecting institutional inertia that impedes the redistribution of cross-sector resources. Agency collaboration evolved from a siloed approach (2015-2018) to a networked structure (2019-2021) and transitioned to centralized governance post-2022. Thematic shifts in policy discourse moved from a "Healthy China" focus toward pandemic-driven disease surveillance, culminating in the recent development of smart health ecosystems.

conclusionsChina's policies for medical-preventive integration demonstrate notable structural imbalances, particularly in the economic instruments related to health financing and the private-sector participation in healthcare. These imbalances may impede the effective allocation of healthcare resources and hinder the seamless transition toward integrated care. Future policy efforts should focus on optimizing the structure of policy instruments, addressing gaps in the full lifecycle of health services, advancing integration reforms, and promoting the transformation of the healthcare system through enhanced collaborative governance among key stakeholders.

Indexed as

LDA topic modelingmedical-preventive integrationpolicy instrumentstructural imbalance

Identifiers

PMID42194464
PMCPMC13205401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.